Growing community of inventors

Montreal, Canada

Jeffrey S Albert

Average Co-Inventor Count = 6.40

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Jeffrey S AlbertAndrew Griffin (6 patents)Jeffrey S AlbertShawn Donald Johnstone (6 patents)Jeffrey S AlbertMalken Bayrakdarian (6 patents)Jeffrey S AlbertStephen Claridge (5 patents)Jeffrey S AlbertGuillaume Jacquemot (5 patents)Jeffrey S AlbertMehrnaz Pourashraf (4 patents)Jeffrey S AlbertMarc-Andre Beaulieu (1 patent)Jeffrey S AlbertMalken Bayrakdarian (1 patent)Jeffrey S AlbertAndrew Griffin (1 patent)Jeffrey S AlbertMehrnaz Pourashraf (1 patent)Jeffrey S AlbertJeffrey S Albert (6 patents)Andrew GriffinAndrew Griffin (22 patents)Shawn Donald JohnstoneShawn Donald Johnstone (13 patents)Malken BayrakdarianMalken Bayrakdarian (9 patents)Stephen ClaridgeStephen Claridge (20 patents)Guillaume JacquemotGuillaume Jacquemot (5 patents)Mehrnaz PourashrafMehrnaz Pourashraf (4 patents)Marc-Andre BeaulieuMarc-Andre Beaulieu (1 patent)Malken BayrakdarianMalken Bayrakdarian (1 patent)Andrew GriffinAndrew Griffin (1 patent)Mehrnaz PourashrafMehrnaz Pourashraf (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Neomed Institute (4 from 10 patents)

2. Epigenetix, Inc. (2 from 2 patents)


6 patents:

1. 11981657 - Substituted benzimidazoles, their preparation and their use as pharmaceuticals

2. 11365186 - Substituted benzimidazoles, their preparation and their use as pharmaceuticals

3. 10836742 - N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals

4. 10703740 - Substituted benzimidazoles, their preparation and their use as pharmaceuticals

5. 10501438 - Aryl-substituted dihydroquinolinones, their preparation and their use as pharmaceuticals

6. 10501459 - Substituted imidazo[1,2-a]pyridines as bromodomain inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…